The purpose of this study is to explore whether Medibio’s system can provide objective measures of response to standard medication treatment for unipolar depression and bipolar depression, and to see ...

Otsuka has recruited mental health tech company Medibio to help assess the effectiveness of its schizophrenia and bipolar disorder treatment Abilify. Approved since 2002, Abilify (aripiprazole ...